Apolipoprotein A-I (APOA1) Antibody (FITC)

Este producto es parte de APOA1 - Apolipoprotein A1
Apolipoprotein A-I (APOA1) Antibody (FITC)
260€ (50 µl)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

Name
Apolipoprotein A-I (APOA1) Antibody (FITC)
Category
Primary Antibodies
Provider
Abbexa
Reference
abx341251

Description

Apolipoprotein A-I (APOA1) Antibody (FITC) is a Rabbit Polyclonal antibody conjugated to FITC for the detection of Rat Apoa1.

Documentos del producto

Instrucciones
Data sheet
Descargar

Especificaciones del producto

Category
Primary Antibodies
Immunogen Target
Target: Apolipoprotein A-I (APOA1)
Immunogen: Recombinant Rat Apoa1 protein (19-259 AA)
Host
Rabbit
Reactivity
Rat
Detection Method
Laser Line: 488
Excitation/Emission: 499/515
Recommended Dilution
Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
FITC
Isotype
IgG
Purity
> 95%
Purification
Purified by antigen affinity chromatography.
Size 1
50 µl
Size 2
100 µl
Size 3
200 µl
Size 4
1 ml
Form
Liquid
Buffer
0.01 M PBS, pH 7.4, 0.03% Proclin-300 and 50% glycerol.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
P04639
Gene ID
25081
Alias
Apo A1,Apo-A1,apo(a), apolipoprotein A1, Apolipoprotein A-I,HPALP2,APOA1,Apolipoprotein AI
Background
Antibody anti-APOA1
Status
RUO
Note
THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.

Background

APOA1 is the primary protein component of high-density lipoprotein (HDL), often referred to as "good cholesterol," where it plays a crucial role in reverse cholesterol transport. APOA1 facilitates the removal of cholesterol from peripheral tissues and delivers it to the liver for excretion via bile, thus protecting against atherosclerosis and cardiovascular disease. APOA1 is also an activator of lecithin-cholesterol acyltransferase (LCAT), an enzyme critical for HDL maturation and cholesterol esterification. Mutations in the APOA1 gene can result in familial HDL deficiency or amyloidosis, leading to cardiovascular dysfunction and systemic deposits of amyloid fibrils. As a key modulator of lipid metabolism, APOA1 is a major therapeutic target for managing dyslipidemia and reducing cardiovascular risk.

Productos relacionados

abx001043

Apolipoprotein A1 (APOA1) Antibody

APOA1 Antibody is a Rabbit Polyclonal antibody against APOA1. This gene encodes apolipoprotein A-I, which is the major p…

Ver producto
abx010413

Apolipoprotein A1 (APOA1) Antibody

APOA1: apolipoprotein A-I, it is the major protein component of high density lipoprotein (HDL) in plasma. The protein pr…

Ver producto
abx018162

Apolipoprotein A-I (Apo-AI) Antibody

Apo-AI Antibody is a Mouse Monoclonal antibody against Apo-AI.…

Ver producto